Hexo: Analysts Anticipate $34.4 Million In Q3 Revenues

Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced that they will be reporting their fiscal third quarter financials before the market opens on June 14th.

Analysts have a consensus C$9.47 12-month price target on the company, via a total of 25 analysts, with three analysts having buy ratings, eight analysts have hold ratings and a single analyst has a strong sell rating. The street high comes from Alliance Global with a C$14 price target, and the lowest target comes from Bryan Garnier with a C$4 price target.

10 analysts have revenue estimates for the third quarter. The mean between all 10 is C$34.42 million; this number has been steady since the start of the year. The street high is C$36.90 million while the lowest sits at C$28.30 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 36.08%, with this number being flat since the start of the year. Street high goes to Stifel-GMP with a 37% estimate and the lowest sits at 35.1%.

Onto EBITDA estimates, there are currently 10 analysts who have third quarter EBITDA estimates. The mean is currently C$0.068 million, with this number being lower at the start of the year. Street high goes to Oppenheimer with a C$2.6 million EBITDA estimate and the lowest being a (C$2) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why This War Made the Gold Case Stronger | Michael Gentile

Wall Street Bought the Ceasefire. Now Oil’s Back Over $100 | Todd Bubba Horwitz

Canada’s Soft Spot: Why Every Canadian Manufacturer Should Be Watching the July 1st CUSMA Negotiation

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Ascend Wellness: Canaccord Initiates With US$15 Price Target

Canaccord Genuity is the first investment bank to initiate coverage on Ascend Wellness (CSE: AAWH.u)....

Tuesday, May 25, 2021, 03:12:00 PM

Emerge Commerce Sees Canaccord Reiterate $1.20 Price Target

On November 29th, Emerge Commerce (TSXV: ECOM) announced its third quarter financial results. The company...

Thursday, December 2, 2021, 03:33:00 PM

Molson Coors, Hexo Enter Joint Venture For US CBD Beverages

It appears that Molson Coors (TSX: TPX) (NYSE: TAP) is still interested in working with...

Wednesday, April 15, 2020, 09:21:16 AM

WeedMD: Canaccord Reiterates Price Target After Earnings

WeedMD (TSXV: WMD) reported their first-quarter financials of 2021 on June 29th. The company reported...

Thursday, July 1, 2021, 03:09:00 PM

Cameco: Canaccord Refers To Firm As “Go-To” Name For Uranium Exposure

On February 9th, Cameco (TSX: CCO) reported its full-year 2021 financial results. The company reported...

Saturday, February 12, 2022, 02:03:00 PM